CVR number 30199154
Industry 75.0000 Veterinary activities

FYNS DYRLÆGEHUS ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...
Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  12.1% 13.2% 13.4% 12.0% 10.9%  
Credit score (0-100)  21 17 16 19 21  
Credit rating  BB BB BB BB BB  
Credit limit (kDKK)  -0.0 -0.0 -0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  119 129 154 169 0  
Gross profit  30.4 26.1 14.2 10.3 12.5  
EBITDA  -1.9 2.2 0.3 2.5 12.5  
EBIT  -1.9 2.2 0.3 2.5 12.5  
Pre-tax profit (PTP)  -2.0 2.0 0.0 2.1 13.0  
Net earnings  -2.0 2.0 0.0 2.1 13.0  
Pre-tax profit without non-rec. items  -2.0 2.0 0.0 2.1 13.0  
 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  -67.8 -65.8 -65.8 -63.7 -50.7  
Interest-bearing liabilities  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  162 216 202 214 236  
Net Debt  -3.7 -14.7 -46.8 -124 -222  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales  119 129 154 169 0  
Net sales growth  19.0% 8.3% 19.4% 9.9% -100.0%  
Gross profit  30.4 26.1 14.2 10.3 12.5  
Gross profit growth  0.0% -14.1% -45.7% -27.5% 21.4%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  162 216 202 214 236  
Balance sheet change%  7.4% 33.3% -6.2% 5.8% 10.2%  
Added value  -1.9 2.2 0.3 2.5 12.5  
Added value %  -1.6% 1.7% 0.2% 1.5% 0.0%  
Investments  0 0 0 0 0  
Net sales trend  1.0 2.0 3.0 4.0 -1.0  
EBIT trend  -2.0 1.0 2.0 3.0 4.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  -1.6% 1.7% 0.2% 1.5% 0.0%  
EBIT %  -1.6% 1.7% 0.2% 1.5% 0.0%  
EBIT to gross profit (%)  -6.2% 8.3% 2.2% 24.6% 100.0%  
Net Earnings %  -1.7% 1.6% 0.0% 1.3% 0.0%  
Profit before depreciation and extraordinary items %  -1.7% 1.6% 0.0% 1.3% 0.0%  
Pre tax profit less extraordinaries %  -1.7% 1.6% 0.0% 1.3% 0.0%  
ROA %  -0.8% 0.9% 0.1% 0.9% 4.6%  
ROI %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROE %  -1.3% 1.1% 0.0% 1.0% 5.8%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  -29.5% -23.4% -24.5% -22.9% -17.7%  
Relative indebtedness %  193.0% 218.5% 174.3% 164.4% 0.0%  
Relative net indebtedness %  189.9% 207.1% 143.9% 91.2% 0.0%  
Net int. bear. debt to EBITDA, %  195.2% -676.0% -15,244.0% -4,891.4% -1,780.4%  
Gearing %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 0.0% 0.0% 0.0%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.5 0.5 0.5 0.6 0.8  
Current Ratio  0.7 0.8 0.8 0.8 0.8  
Cash and cash equivalent  3.7 14.7 46.8 123.8 222.0  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  277.7 310.0 232.2 74.7 0.0  
Trade creditors turnover (days)  18.4 117.6 3.9 18.8 0.0  
Current assets / Net sales %  136.0% 167.5% 131.6% 126.8% 0.0%  
Net working capital  -67.8 -65.8 -65.8 -63.7 -50.7  
Net working capital %  -57.0% -51.1% -42.8% -37.7% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0